Ocular Therapeutix

OCULNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.018 B

$9.19 +5.15%

Close of 7 Aug 2026

Revenue

$52.0M

#2729 by revenue

Earnings

-$265.9M

Loss-making

Shares outstanding

219,615,868

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#113Zenas BioPharmaZBIO$2.05B
#114AbCellera BiologicsABCL$2.04B
#115Ocular TherapeutixOCUL$2.02B
#116Agios PharmaceuticalsAGIO$1.93B
#117COMPASS PathwaysCMPS$1.87B

Where these numbers come from

Share counts and financials for Ocular Therapeutix are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.